News

Member Press Releases | Apr 22, 2025

Ability Bio – Life sciences in Montréal: Jadco Group announces that its scientific hub, Inspire Bio Innovations, will be home to the next-generation targeted therapeutics company Ability Biotherapeutics

Member Press Releases | Apr 22, 2025

CASTL – Navigating the Talent Landscape: Labour Market Information Shaping the Biomanufacturing Workforce

Member Press Releases | Apr 08, 2025

Medicenna: London to Host Pivotal Event Spotlighting Canada’s Leadership in Biotech, Innovation, and Youth Talent

Member Press Releases | Apr 08, 2025

ViewsML and Dartmouth Health Partner to Advance AI-Driven Virtual Biomarkers and Diagnostics

Statements & Submissions | Mar 26, 2025

All Provinces and Territories Signed On: A Milestone for Rare Disease Patients

Statements & Submissions | Mar 19, 2025

BIOTECanada Submits Feedback on PMPRB Draft Guidelines

Statements & Submissions | Mar 14, 2025

BIOTECanada welcomes Prime Minister Mark Carney and the newly appointed federal cabinet

Statements & Submissions | Mar 12, 2025

2025 Pre-Budget Submission

Member Press Releases | Mar 11, 2025

Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics

Member Press Releases | Mar 07, 2025

Future-Ready: Building Canada’s Biomanufacturing Workforce

Statements & Submissions | Feb 28, 2025

BIOTECanada Statement on Rare Disease Day

Member Press Releases | Feb 21, 2025

CQDM, IVADO, and three Quebec-based companies invest $2M to accelerate the development of highly targeted, less toxic cancer therapies using AI

Member Press Releases | Feb 14, 2025

Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership

Statements & Submissions | Feb 06, 2025

BIOTECanada responds to CDA-AMC’s consultation on proposed improvements to the reimbursement review process

Statements & Submissions | Feb 05, 2025

BIOTECanada Statement on Deferred Implementation of Capital Gains Tax Increase

Member Press Releases | Feb 05, 2025

Life Sciences Ontario Celebrates Excellence and Innovation in Life Sciences with 2025 Awards Announcement

Member Press Releases | Jan 29, 2025

Aspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics

Statements & Submissions | Dec 17, 2024

Canada’s Biotechnology Sector Welcomes Federal Economic Statement’s Measures to Grow Availability of Canadian Investment Dollars and Enhance SR&ED Competitiveness

Member Press Releases | Dec 05, 2024

GlycoNet and partners invest $12 million in Canadian glycomics research to advance health and agriculture

Statements & Submissions | Nov 26, 2024

BIOTECanada CUSMA Consultations

Media Mentions | Nov 07, 2024

Three years and waiting for Canada’s made-in-Montreal COVID shot

Member Press Releases | Oct 30, 2024

Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development

Member Press Releases | Oct 24, 2024

Epitopea Closes USD $31 million Pre-Series A Financing

Statements & Submissions | Oct 24, 2024

Building a Strategic Foresight Framework to Support System Readiness for AdvancedTherapeutic Products in Canada

Press Releases | Oct 09, 2024

BIOTECanada Welcomes Three New Members to its Board of Directors

Media Mentions | Oct 06, 2024

Vaccine manufacturer won’t be making COVID shots at Montreal plant this winter

Member Press Releases | Sep 19, 2024

Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster

Media Mentions | Sep 18, 2024

Canada’s biotech carpe diem

Member Press Releases | Sep 16, 2024

Find Therapeutics Announces the Closing of a Convertible Note Financing with Investissement Québec

Statements & Submissions | Sep 11, 2024

BIOTECanada PMPRB Consultation

Statements & Submissions | Sep 11, 2024

Vaccine Industry Committee (VIC): PMPRB Consultation

Member Press Releases | Sep 10, 2024

Entos led UofA-Dalhousie study published in Cell – “Safe and Effective Delivery of DNA and RNA Using PLV”

Member Press Releases | Sep 05, 2024

HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 (CA $4.3) Million Seed Financing

Member Press Releases | Sep 04, 2024

Feldan Therapeutics completes a US$ 21 Million series b financing co-led by Genesys Capital and Fonds de solidarité FTQ

Statements & Submissions | Sep 03, 2024

Budget 2024 Capital Gains Tax Increase Consultation

Member Press Releases | Aug 27, 2024

Find Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Study of FTX-101 for the Treatment of Chronic Optic Neuropathy

Statements & Submissions | Aug 09, 2024

Modernize NSNR

Statements & Submissions | Aug 02, 2024

BIOTECanada’s 2025 Pre-Budget Submission

Statements & Submissions | Aug 01, 2024

Vaccine Industry Committee (VIC): Pre-Budget Submission

Statements & Submissions | Jul 24, 2024

BIOTECanada’s response to bilateral agreements between the Government of Canada and the Province of British Columbia to improve patient access to drugs for rare diseases

Press Releases | Jun 03, 2024

BIOTECanada Opens the Canada Pavilion at BIO International Convention

Press Releases | May 31, 2024

BIOTECanada Hosts Annual General Meeting and Announces New Chair of the Board of Directors

Statements & Submissions | May 29, 2024

Message to Members of BIOTECanada from the Board of Directors

Statements & Submissions | May 27, 2024

BIOTECanada’s Response to SR&ED Phase 2

Statements & Submissions | May 25, 2024

BIOTECanada’s submission on Bill C64 An Act respecting pharmacare

Media Mentions | May 01, 2024

Embracing regulatory ambition to shape Canada’s future in health-care innovation

Media Mentions | Apr 25, 2024

Capital gains tax changes are a setback for Canadian biotech competitiveness

Media Mentions | Apr 22, 2024

A Capital Gains Tax Increase? Now?

Press Releases | Apr 17, 2024

2024 Federal Budget Recognizes the Critical Role of Canada’s Biotech Industry

Statements & Submissions | Apr 15, 2024

BIOTECanada’s Submission on Patent Box (Creating a Patent Box Regime)

Statements & Submissions | Apr 15, 2024

BIOTECanada’s Submission on SRED Consultation

Media Mentions | Apr 02, 2024

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Media Mentions | Mar 14, 2024

Poutine and proteins: Biotech in Canada

Statements & Submissions | Mar 04, 2024

BIOTECanada Statement on Federal Announcement of Pharmacare Legislation-Bill C-64

Media Mentions | Feb 20, 2024

Investment Reports

Press Releases | Sep 29, 2023

Celebrating the Best in Canadian Biotech: BIOTECanada Announces 2023 Gold Leaf Award Winners

Media Mentions | Sep 11, 2023

Biotech sector is having a generational moment in Canada

Statements & Submissions | Aug 18, 2023

BIOTECanada responds to the pCPA’s pTAP proposal

Press Releases | Jun 27, 2023

BIOTECanada Announces Addition of Directors to Board of Directors

Statements & Submissions | May 01, 2023

BIOTECanada responds to CADTH’s proposal on Time-Limited Recommendations

Media Mentions | Apr 27, 2023

Time to Recapture Momentum for Vaccines and Immunization

Press Releases | Mar 22, 2023

BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases

Statements & Submissions | Mar 16, 2023

BIOTECanada Welcomes New Council of Expert Advisors

Media Mentions | Oct 13, 2022

How Canadian biotech can lead in the solutions of the future

Press Releases | Sep 28, 2022

Canadian Biotech Industry Recognizes Top Performers

Media Mentions | Sep 27, 2022

Canada’s biotech ecosystem at an inflection point

Media Mentions | Sep 22, 2022

How to Grow Canada’s Biotech Sector

Press Releases | May 31, 2022

BIOTECanada Announces Addition of Directors to Board of Directors

Press Releases | Apr 20, 2022

Statement on Federal Decision on Regulations Governing PMPRB

Press Releases | Apr 08, 2022

BIOTECanada Welcomes Federal Budget’s Commitment to Canadian Biotech Industry

Press Releases | Jan 05, 2022

BIOTECanada is Supportive of the Implementation Delay for Changes to the PMPRB Recently Announced by the Government of Canada

Press Releases | Nov 28, 2021

BIOTECanada Supports Federal Government’s Commitment to Biomanufacturing Sector

Press Releases | Oct 26, 2021

BIOTECanada Welcomes Federal Cabinet Announcement

Media Mentions | Sep 21, 2021

The Canadian biotechnology industry’s moment

Press Releases | Sep 21, 2021

BIOTECanada Congratulates Liberal Party on Election Victory

Press Releases | Jul 28, 2021

BIOTECanada Supports Government of Canada’s Biomanufacturing Strategy

Press Releases | Jun 29, 2021

Statement From BIOTECanada Regarding PMPRB Implementation Delay

Press Releases | Jun 08, 2021

Canadian Biotech Industry Ready to Wave the Flag at BIO Digital

Press Releases | Jun 03, 2021

BIOTECanada Board Announces Addition of Directors and New Chair

Media Mentions | Apr 30, 2021

Significant Investment For Canadian Bio-Manufacturing

Press Releases | Apr 23, 2021

Proposed TRIPS Waiver for Intellectual Property

Press Releases | Apr 19, 2021

Federal Budget Recognizes Strategic Importance of Canada’s Biotech Sector

Press Releases | Apr 15, 2021

BIOTECanada and Cognit.ca launch initiative to help biotechnology industry mobilize university and hospital research

Press Releases | Apr 09, 2021

BIOTECanada Outlines the Vast Economic Recovery Opportunity for Canada in the Upcoming Federal Budget

Press Releases | Mar 31, 2021

BIOTECanada Supports Sanofi Announcement Investing in Canadian Biomanufacturing Capacity

Media Mentions | Jan 12, 2021

Spotlight on biotech in Canada

Media Mentions | Nov 20, 2020

Holistic Policy Needed to Grow Biotech in Canada

Media Mentions | Nov 20, 2020

Vaccine Manufacturing in Canada

Media Mentions | Jan 24, 2025

Building a global biotechnology powerhouse in Canada

Media Mentions | Nov 07, 2024

Three years and waiting for Canada’s made-in-Montreal COVID shot

Media Mentions | Oct 06, 2024

Vaccine manufacturer won’t be making COVID shots at Montreal plant this winter

Media Mentions | Sep 18, 2024

Canada’s biotech carpe diem

Media Mentions | May 01, 2024

Embracing regulatory ambition to shape Canada’s future in health-care innovation

Media Mentions | Apr 25, 2024

Capital gains tax changes are a setback for Canadian biotech competitiveness

Media Mentions | Apr 22, 2024

A Capital Gains Tax Increase? Now?

Media Mentions | Apr 02, 2024

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Media Mentions | Mar 14, 2024

Poutine and proteins: Biotech in Canada

Media Mentions | Feb 20, 2024

Investment Reports

Media Mentions | Sep 11, 2023

Biotech sector is having a generational moment in Canada

Media Mentions | Apr 27, 2023

Time to Recapture Momentum for Vaccines and Immunization

Media Mentions | Oct 13, 2022

How Canadian biotech can lead in the solutions of the future

Media Mentions | Sep 27, 2022

Canada’s biotech ecosystem at an inflection point

Media Mentions | Sep 22, 2022

How to Grow Canada’s Biotech Sector

Media Mentions | Sep 21, 2021

The Canadian biotechnology industry’s moment

Media Mentions | Apr 30, 2021

Significant Investment For Canadian Bio-Manufacturing

Media Mentions | Jan 12, 2021

Spotlight on biotech in Canada

Media Mentions | Nov 20, 2020

Holistic Policy Needed to Grow Biotech in Canada

Media Mentions | Nov 20, 2020

Vaccine Manufacturing in Canada

Member Press Releases | Apr 22, 2025

Ability Bio – Life sciences in Montréal: Jadco Group announces that its scientific hub, Inspire Bio Innovations, will be home to the next-generation targeted therapeutics company Ability Biotherapeutics

Member Press Releases | Apr 22, 2025

CASTL – Navigating the Talent Landscape: Labour Market Information Shaping the Biomanufacturing Workforce

Member Press Releases | Apr 08, 2025

Medicenna: London to Host Pivotal Event Spotlighting Canada’s Leadership in Biotech, Innovation, and Youth Talent

Member Press Releases | Apr 08, 2025

ViewsML and Dartmouth Health Partner to Advance AI-Driven Virtual Biomarkers and Diagnostics

Member Press Releases | Mar 11, 2025

Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics

Member Press Releases | Mar 07, 2025

Future-Ready: Building Canada’s Biomanufacturing Workforce

Member Press Releases | Feb 21, 2025

CQDM, IVADO, and three Quebec-based companies invest $2M to accelerate the development of highly targeted, less toxic cancer therapies using AI

Member Press Releases | Feb 14, 2025

Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership

Member Press Releases | Feb 05, 2025

Life Sciences Ontario Celebrates Excellence and Innovation in Life Sciences with 2025 Awards Announcement

Member Press Releases | Jan 29, 2025

New $24 million funding to spearhead pandemic preparedness research

Member Press Releases | Jan 16, 2025

CASTL launches its 2025 biomanufacturing training Course Catalogue

Member Press Releases | Jan 14, 2025

EnAbling Change

Member Press Releases | Jan 08, 2025

Aspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics

Member Press Releases | Dec 05, 2024

GlycoNet and partners invest $12 million in Canadian glycomics research to advance health and agriculture

Member Press Releases | Oct 30, 2024

Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development

Member Press Releases | Oct 24, 2024

Epitopea Closes USD $31 million Pre-Series A Financing

Member Press Releases | Sep 19, 2024

Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster

Member Press Releases | Sep 16, 2024

Find Therapeutics Announces the Closing of a Convertible Note Financing with Investissement Québec

Member Press Releases | Sep 10, 2024

Entos led UofA-Dalhousie study published in Cell – “Safe and Effective Delivery of DNA and RNA Using PLV”

Member Press Releases | Sep 05, 2024

HDAX Therapeutics Announces First Closing of Oversubscribed US $3.2 (CA $4.3) Million Seed Financing

Member Press Releases | Sep 04, 2024

Feldan Therapeutics completes a US$ 21 Million series b financing co-led by Genesys Capital and Fonds de solidarité FTQ

Member Press Releases | Aug 27, 2024

Find Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Study of FTX-101 for the Treatment of Chronic Optic Neuropathy

Press Releases | Jan 10, 2025

BIOTECanada welcomes new President & CEO

Press Releases | Oct 09, 2024

BIOTECanada Welcomes Three New Members to its Board of Directors

Press Releases | Jun 03, 2024

BIOTECanada Opens the Canada Pavilion at BIO International Convention

Press Releases | May 31, 2024

BIOTECanada Hosts Annual General Meeting and Announces New Chair of the Board of Directors

Press Releases | Apr 17, 2024

2024 Federal Budget Recognizes the Critical Role of Canada’s Biotech Industry

Press Releases | Sep 29, 2023

Celebrating the Best in Canadian Biotech: BIOTECanada Announces 2023 Gold Leaf Award Winners

Press Releases | Jun 27, 2023

BIOTECanada Announces Addition of Directors to Board of Directors

Press Releases | Mar 22, 2023

BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases

Press Releases | Sep 28, 2022

Canadian Biotech Industry Recognizes Top Performers

Press Releases | May 31, 2022

BIOTECanada Announces Addition of Directors to Board of Directors

Press Releases | Apr 20, 2022

Statement on Federal Decision on Regulations Governing PMPRB

Press Releases | Apr 08, 2022

BIOTECanada Welcomes Federal Budget’s Commitment to Canadian Biotech Industry

Press Releases | Jan 05, 2022

BIOTECanada is Supportive of the Implementation Delay for Changes to the PMPRB Recently Announced by the Government of Canada

Press Releases | Nov 28, 2021

BIOTECanada Supports Federal Government’s Commitment to Biomanufacturing Sector

Press Releases | Oct 26, 2021

BIOTECanada Welcomes Federal Cabinet Announcement

Press Releases | Sep 21, 2021

BIOTECanada Congratulates Liberal Party on Election Victory

Press Releases | Jul 28, 2021

BIOTECanada Supports Government of Canada’s Biomanufacturing Strategy

Press Releases | Jun 29, 2021

Statement From BIOTECanada Regarding PMPRB Implementation Delay

Press Releases | Jun 08, 2021

Canadian Biotech Industry Ready to Wave the Flag at BIO Digital

Press Releases | Jun 03, 2021

BIOTECanada Board Announces Addition of Directors and New Chair

Press Releases | Apr 23, 2021

Proposed TRIPS Waiver for Intellectual Property

Press Releases | Apr 19, 2021

Federal Budget Recognizes Strategic Importance of Canada’s Biotech Sector

Press Releases | Apr 15, 2021

BIOTECanada and Cognit.ca launch initiative to help biotechnology industry mobilize university and hospital research

Press Releases | Apr 09, 2021

BIOTECanada Outlines the Vast Economic Recovery Opportunity for Canada in the Upcoming Federal Budget

Press Releases | Mar 31, 2021

BIOTECanada Supports Sanofi Announcement Investing in Canadian Biomanufacturing Capacity

Statements & Submissions | Mar 26, 2025

All Provinces and Territories Signed On: A Milestone for Rare Disease Patients

Statements & Submissions | Mar 19, 2025

BIOTECanada Submits Feedback on PMPRB Draft Guidelines

Statements & Submissions | Mar 14, 2025

BIOTECanada welcomes Prime Minister Mark Carney and the newly appointed federal cabinet

Statements & Submissions | Mar 12, 2025

2025 Pre-Budget Submission

Statements & Submissions | Feb 28, 2025

BIOTECanada Statement on Rare Disease Day

Statements & Submissions | Feb 06, 2025

BIOTECanada responds to CDA-AMC’s consultation on proposed improvements to the reimbursement review process

Statements & Submissions | Feb 05, 2025

BIOTECanada Statement on Deferred Implementation of Capital Gains Tax Increase

Statements & Submissions | Jan 27, 2025

Drugs for rare diseases bilateral agreements

Statements & Submissions | Dec 17, 2024

Canada’s Biotechnology Sector Welcomes Federal Economic Statement’s Measures to Grow Availability of Canadian Investment Dollars and Enhance SR&ED Competitiveness

Statements & Submissions | Nov 26, 2024

BIOTECanada CUSMA Consultations

Statements & Submissions | Oct 24, 2024

Building a Strategic Foresight Framework to Support System Readiness for AdvancedTherapeutic Products in Canada

Statements & Submissions | Sep 11, 2024

BIOTECanada PMPRB Consultation

Statements & Submissions | Sep 11, 2024

Vaccine Industry Committee (VIC): PMPRB Consultation

Statements & Submissions | Sep 03, 2024

Budget 2024 Capital Gains Tax Increase Consultation

Statements & Submissions | Aug 09, 2024

Modernize NSNR

Statements & Submissions | Aug 02, 2024

BIOTECanada’s 2025 Pre-Budget Submission

Statements & Submissions | Aug 01, 2024

Vaccine Industry Committee (VIC): Pre-Budget Submission

Statements & Submissions | Jul 24, 2024

BIOTECanada’s response to bilateral agreements between the Government of Canada and the Province of British Columbia to improve patient access to drugs for rare diseases

Statements & Submissions | May 29, 2024

Message to Members of BIOTECanada from the Board of Directors

Statements & Submissions | May 27, 2024

BIOTECanada’s Response to SR&ED Phase 2

Statements & Submissions | May 25, 2024

BIOTECanada’s submission on Bill C64 An Act respecting pharmacare

Statements & Submissions | Apr 15, 2024

BIOTECanada’s Submission on Patent Box (Creating a Patent Box Regime)

Statements & Submissions | Apr 15, 2024

BIOTECanada’s Submission on SRED Consultation

Statements & Submissions | Mar 04, 2024

BIOTECanada Statement on Federal Announcement of Pharmacare Legislation-Bill C-64

Statements & Submissions | Aug 18, 2023

BIOTECanada responds to the pCPA’s pTAP proposal

Statements & Submissions | May 01, 2023

BIOTECanada responds to CADTH’s proposal on Time-Limited Recommendations

Statements & Submissions | Mar 16, 2023